EMulate Therapeutics, Inc. (EMTX)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	69.31M
Revenue (ttm)	255,000 +113.3%
Net Income	-28.02M
EPS	-2.02
Shares Out	13.86M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About EMTX

EMulate Therapeutics is on a mission to advance the development and adoption of medical, health, and environmental applications of our low-to-ultra-low radio frequency energy technology that are determined by the FDA (or other applicable regulators) to be non-toxic, non-invasive, non-ionizing, safe and effective. We have invented and patented what we believe to be a groundbreaking technology that utilizes radio frequency energy (RFE) precisely targeted at the low and ultra-low ends of the RFE spectrum (ulRFE®) to specifically regulate signaling...

• Industry: Health Care
• Sector: Health Care Equipment & Supplies
• Founded: 2002
• Employees: 7
• Stock Exchange: NASDAQ
• Ticker Symbol: EMTX
• Website: https://www.emulatetx.com/

Financial Performance

Data Source: SEC filings Last updated: Sep 4, 2026

The data for this page was gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Data Sources Report a data error